Astra

OpenAI says it will not release its newest Astra AI model, citing safety concerns. According to a New York Times report, the company has decided to hold the model back rather than make it publicly available, a step that has drawn attention in ongoing debates about how quickly advanced AI systems should be deployed.

OpenAI has cancelled the planned release of a new AI model, referred to as Astra, after internal testing raised safety concerns. The decision means the model will not be made public for now, and it signals that the company is willing to hold back products when internal evaluations flag problems. The move is drawing attention from AI watchers debating how seriously companies weigh safety against competitive pressure.

Posts claim that OpenAI's GPT-6, referred to as 'Astra', has decrypted an Enigma message that had gone unsolved since 2005, referencing the Breaking German Cipher Machine challenges site. Discussion centres on the claim that an AI model succeeded where human codebreakers had failed for two decades. The evidence available is a single headline, and details about how the message was cracked have not been confirmed from these posts.

OpenAI says it will not release Astra, its newest artificial intelligence model, citing unresolved safety concerns. According to the report, the company decided the model did not meet its internal safety standards for public deployment. The move has sparked debate among AI researchers and industry watchers about how companies weigh safety reviews against competitive pressure to ship new models.

OpenAI has cancelled the release of its AI model GPT-6.1 Astra, citing safety concerns. The decision means the next version of the company's flagship model family will not ship as planned. Reactions so far have focused on what the cancellation signals about how far AI labs are willing to go when internal safety reviews raise red flags.

AstraZeneca has invested $2bn in US biotech firm Summit Therapeutics as part of a major cancer research collaboration. The FTSE 100 drugmaker agreed to buy 109,000 shares in the Nasdaq-listed company at $18.36 per share, funding a tie-up aimed at developing new cancer treatments.

OpenAI has scrapped the planned release of its Astra 6.1 model, citing unresolved safety issues, according to a Washington Post report. The decision means the ChatGPT maker will hold back an update to its AI system rather than ship it on schedule. The report has drawn wide attention online, with commenters debating what safety problems could be serious enough for the company to pull a completed model just before launch.

OpenAI has shelved Astra, an internal project reportedly dropped over concerns that it would not stay within the company's intended scope or focus. The news, reported by Business Insider, offers a rare glimpse into how OpenAI decides which experimental efforts to pursue and which to abandon as it juggles competing priorities across its product roadmap.

OpenAI has cancelled the launch of its GPT-6.1 Astra model after it failed to meet the company's internal safety standards. The decision means the next-generation system will not be released as planned, and attention now turns to how OpenAI will address the safety gaps before any future rollout.

The Texas Observer has published a magazine feature examining the work of authors Naomi Klein and Astra Taylor, who propose a framework for analyzing what they call a world of perpetual upheavals and strategies to combat it. The piece questions whether the model of resistance the two writers offer is sufficient for the current political moment.